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1. Introduction  
The immune system comprises complex cellular and humoral systems, which are forming 
an interactive network to recognize and eradicate invading pathogens. Foreign molecules 
present on viruses, bacteria and parasites, but not on host cells, are discriminated from self 
through pathogen-associated molecular patterns. Upon entry of the pathogen into the body 
immediate non-specific immune responses are triggered and within a short time the innate 
immune system is completely activated. The innate immune system is composed of multiple 
humoral and cellular players, including cytokines, complement proteins, acute-phase 
proteins, dendritic cells, macrophages, NK cells, that co-operate in a complex to generate an 
efficient defense against infection (Figure 1). At best, these immediate innate immune 
responses are able to clear infection or bridge the period until the adaptive, specific immune 
response is taking effect. 
 
 
Fig. 1. Induction of Immune responses 
Among the first components activated during the innate immune response is the 
complement system that together with interferons, cytokines and chemokines stimulate 
innate immune cells, such as dendritic cells (DCs), natural killer (NK) cells, natural killer T 
(NKT) cells, monocytes, or macrophages. These factors act in concert until the adaptive arm 
of immunity is established. Thus, to control the infection process in the acute phase a co-
ordinated action of the innate immune elements is essential.  
In the beginning of an infection viruses and microbes developed different strategies to avoid 
the attack of the innate immune system. Also the human immunodeficiency virus (HIV) is 






thereby attenuates the immunity of the host. In the last years the interest in innate immune 
responses to control HIV infection significantly increased and this book chapter will 
describe various interactions and evasion strategies of HIV and innate immune elements 
with a special focus on complement and dendritic cells.  
2. Interactions of HIV with humoral components of the innate immune system 
Following entry of HIV into the host, humoral components of the innate immune system, 
such as complement system, interferons, cyto- and chemokines, are spontaneously activated 
and will be discussed here. Together with dendritic cells, which are among the first cells of 
the immune system to interact with HIV, the innate humoral components attract other cells 
of the immune system, e.g. NK cells or macrophages, to the sites of infection and a first line 
of defense is established. To ensure a logical configuration of the chapter, we will first 
summarize interactions of HIV with humoral components of the innate system and 
subsequently with cellular responses, although these actions cannot be separated and are 
proceeding in parallel at mucosal surfaces. 
2.1 Interactions of HIV with the complement system 
The complement system plays a crucial role during viral infection respecting both innate 
and adaptive immune responses. It constitutes the first barrier to control HIV propagation 
and can be activated via three different biochemical pathways: the classical, the MBL, and 
the lectin pathway (Fig. 2). The classical complement pathway was the first way to be 
identified, and activation of the classical pathway occurs when the first component of the 
pathway, C1, binds the Fc region of either natural or specific IgG antibody immune-
complexed with viral antigen. The classical pathway is also triggered in an antibody-
independent manner when C1 directly binds to virions or infected cells.  
The alternative pathway is activated by direct recognition of certain microbial structures 
and the (mannan-binding) lectin (MBL) pathway is triggered by binding of terminal 
mannose residues on microbial glycoproteins and glycolipids (Fig. 2). All three pathways 
converge in the cleavage of C3, the main complement component, to the anaphylatoxin C3a 
and the opsonin C3b. This cleavage initiates a cascade of further activation events. C3b is 
covalently deposited on the microbial surface and joins with the C3 convertase to generate 
the C5 convertase. This convertase again cleaves C5 into C5a (anaphylatoxin) and C5b. C5b 
triggers the formation of the membrane attack complex (MAC), that consists of C5b, C6, C7, 
C8 and polymeric C9 molecules (Fig. 2). The formation of the MAC disrupts the microbial 
membrane, resulting in lysis of infected cells or pathogens (Stoiber et al., 2007; Speth et al., 
2008). Figure 2 summarizes the activation events of the complement cascade using the 
example of a viral particle. 
An appropriate control of the over 30 complement proteins, that are participating in the 
activation of the three different complement pathways, is crucial to prevent spontaneous 
activation and destruction of bystander cells. Thus, the complement system is tightly 
controlled by the ‘regulators of complement activation’ or RCAs. RCAs are present in fluid 
phase and also membrane-bound on the surface of host cells. Among the most important 
RCAs are secreted fH (factor H), C4bp (C4-binding protein), MCP (membrane-cofactor 
protein), CD55 (DAF), CD59, and CR1 (Spear et al., 1995; Spiller et al., 1997; Da Costa et al., 
1999; Carroll, 2000).  
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Fig. 2. Activation of Complement (C) 
Upon entering the host HIV-1 spontaneaously activates the complement system via gp120 
and gp41, even in the absence of HIV-specific antibodies, and is hence already coated with 
complement fragments at the initial stages of infection. After seroconversion, adaptive 
immunity is fully activated, as reflected by the generation of specific anti-HIV-1 antibodies 
and activated T cells. Activation of complement is strongly enhanced due to the Ab-C1 
interactions, and deposition of complement fragments on virions dramatically increased by 
virus-bound Abs. Accordingly, opsonized infectious viral particles accumulate in HIV-1-
positive individuals during the acute and chronic phase of infection and complement 
activation results in multifaceted outcomes. Despite the clearance and neutralization of HIV-
1 virions by action of complement, it also accounts for the spread and maintenance of HIV 
during the infection. During the budding process, HIV acquires membrane-anchored RCAs 
such as CD59, CD55 and binds fH in fluid-phase (Frank et al., 1996). Therefore the virus is 
efficiently protected from complement-mediated lysis (CoML). Only at early stages of 
infection, CoML is suggested to contribute to the control of the virus before the adaptive 
immunity is fully activated. At later stages of infection, CoML seems to play a minor role in 
reducing the viral burden in infected individuals (Stoiber et al., 2007; Huber et al., 2008).  
HIV that is not killed by complement-mediated lysis, persists covered with C3 fragments in 
the host. Thus, opsonized HIV accumulates in all so far tested compartments of the host, 
such as blood, lymphatic tissue (LT), brain, mothers milk, or seminal fluid and is able to 
interact with complement receptor (CR)-positive cells, e.g. DCs, macrophages, NK cells, B 
cells or follicular dendritic cells (FDCs). Opsonized virions were found to bind to 
complement receptor-expressing cells, which can promote enhanced viral infectivity and 
transmission in vitro. 
Furthermore, it was shown that complement by itself or together with dendritic cells is 
involved in priming antiviral T cell immunity, therefore suggesting that complement not 
only triggers CoML but mediates adaptive immune responses (Kopf et al., 2002; 
Banki/Posch et al., 2010). C3-deficiency impeded priming of CD4+ and CD8+ T cells in an 
influenza virus model (Kopf et al., 2002), thus supporting this thesis. The exact mechanisms 
of complement-mediated T cell priming have not yet been resolved, but as recently shown, 
priming of naive CD8+ T cells was significantly enhanced when DCs were exposed to 
complement-opsonized HIV compared to DCs stimulated with non-opsonized HIV 
(Banki/Posch et al., 2010). This was also confirmed in vivo using the Friend Murine 
Leukemia Virus model (Banki/Posch et al., 2010). Therefore, the failure to induce efficient T 
cell responses in the absence of complement can be explained by the fact that dendritic cells 






resulting in efficient activation of the adaptive immunity. Without C3 the antigen-presenting 
capacity of DCs, and consequently T cell priming, could be defective, which has to be 
further investigated. In addition, the appropriate cytokine environment for T cell priming 
could be altered in the absence of C3 and therefore weaken antigen-presentation.  
Beside inducing T cell immunity, complement opsonization of HIV particles also accounts 
for the generation of a huge viral reservoir in infected individuals. This can be explained by 
the extracellular binding of C3d-opsonized HIV-particles to follicular dendritic cells (FDCs) 
in germinal centers (Kacani et al., 2000). Up to 90% of viral particles were shown to bind via 
C3d-CR2 interactions on FDCs, creating an additional reservoir for infectious HIV (Pantaleo, 
1995; Haase, 1999).  
In summary, HIV-complement interactions are very complex and contribute on the one 
hand to reduction of the viral load by lysis or neutralization due to opsonization, and on the 
other hand to spread of the virus by allowing attachment and maintenance to and on CR-
expressing cells. 
2.2 Induction of type I interferons and cytokines in acute HIV-infection 
During the early stages of HIV infection, high-level viral replication, loss in CD4+ T cell 
number and function, and an up-regulation of proinflammatory and immunoregulatory 
cytokines can be measured.As recently described, an ordered increase in plasma levels of 
multiple cytokines and chemokines was observed in acute HIV-infection (Stacey et al., 2009):  
 Rapid and transient elevations in IFNǂ and IL-15 levels were succeeded by 
 a large increase in inducible protein 10 (IP-10),  
 rapid and sustained increases in tumor necrosis factor alpha (TNF-ǂ and monocyte 
chemotactic protein-1 (MCP-1),  
 a more slowly induction of proinflammatory cytokines such as IL-6, IL-8, IL-12, and 
IFN-Ǆ and  
 late up-regulation of the immunoregulatory cytokine IL-10.  
Plasmacytoid DCs (pDCs) act as the principal source of systemic IFNǂ production in many 
viral infections. pDCs were shown in vitro to produce cytokines following the endocytosis of 
HIV virions (Beignon et al., 2005) and they are responsible for early elevations in plasma 
IFNǂ, and together with myeloid dermal dendritic cells (DCs) in an early increase of IL-15, 
and TNFǂ levels. Myeloid DCs are made responsible for the slower and more-prolonged 
secretion of an array of cytokines including IL-6, IL-8, IL-12, IL-18, TNFǂ, and IL-10. This 
part of the chapter will review the most important facts about some of the cytokines and 
their functions in acute HIV infection. 
Type I interferons and APOBEC3G in acute HIV infection 
Interferons inhibit viral replication within host cells (“interfere”), but they do also have 
other functions, like activating immune cells, such as NK cells or macrophages, or up-
regulating antigen-presentation to T cells. IFNǂ/ǃ elicit potent antiviral activities in both 
virally infected and non-infected cells (Katze et al., 2002) and they additionally enhance the 
antiviral activity of NK cells and macrophages. Furthermore, IFNǂ/ǃ induce maturation of 
immature pDCs, which is associated with increased expression of CD83, co-stimulatory 
molecules and enhanced secretion of cytokines, e.g. IFNǂ, TNFǂ and IL-6 (Cella et al., 
1999) . IFN-secretion during infection causes symptoms like fever or aching muscles.  
IFNα inhibits HIV replication, the mechanism by which it blocks replication of HIV in vivo 
are not known. The anti-HIV effects of IFNǂ were ascribed to a number of functions 
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mediated by this cytokine, including inhibition of early steps in viral replication, inhibition 
of HIV gene expression, and effects on viral assembly and budding. HIV-1 activates 
plasmacytoid dendritic cells (pDCs) via toll like receptors (TLRs) and induces the secretion 
of IFNǂ. IFNǂ secretion is triggered from pDCs in acute HIV-infection via TLR7, TLR8 or 
TLR9 signaling (Beignon et al., 2005; Lee et al., 2006; Meier et al., 2007; Mandl et al., 2008; 
Zhang et al., 2009). TLRs are pattern recognition receptors (PRRs), which recognize 
conserved motifs specific for microorganisms. Certain viral proteins and viral single- or 
double-stranded RNAs are detected mainly by TLRs 7 [ssRNA]/8 [ssRNA]/9 [dsRNA] 
(Kadowaki et al., 2001; Diebold et al., 2004; Mandl et al., 2008). In acute HIV infection IFNǂ 
has a protective role, while chronic immune activation and inflammation associated with the 
production of type I interferon are major determinants of disease progression in primate 
lentivirus infections (Stoddard et al., 2010). IFNǂ drives the expression of several IFN 
regulatory factors (IRFs), and the induction of IFN-stimulated genes (ISGs) by an autocrine 
positive feedback loop. In turn, ISGs promote proliferation of immune cells and induce an 
antiviral state in cells. 
IFNǂ was also demonstrated to potently induce APOBEC3G (Apolipoprotein B mRNA-
editing enzyme-catalytic polypeptide-like 3G) to abrogate HIV Vif neutralization of 
APOBEC3 proteins (Peng et al., 2006). APOBEC3G, a cytidine deaminase, is an innate 
intracellular protein with lethal activity against HIV and exerts this intrinsic anti–HIV 
activity by introducing lethal G-to-A hypermutations in the viral genome (Casartelli et al., 
2010). While HIV+ patients with progressive disease show a significant decline in pDCs over 
time, long term non-progressors (LTNPs) maintain high levels of these cells and this may be 
of importance in the innate response in these patients. 
TNF- in acute HIV infection 
TNF-ǂis a pro-inflammatory cytokine that mediates many inflammatory and immune 
functions (rev. in Armitage, 1994). It is produced by NK cells, macrophages, monocytes, T 
cells, B cells and neutrophils and exerts its actions via binding to TNF-R1 and TNF-R2. 
Attachment of HIV to TNF-R1 and subsequent activation of NFB were demonstrated to 
significantly increase HIV-1 replication in cells of the macrophage lineage (Griffin et al., 
1991; Naif et al., 1994; Herbein and Gordon, 1997). This enhancement was further amplified 
by IFN-(Han et al., 1996) and a positive autocrine TNF-ǂloop initiated by HIV-1 infection 
of monocyte-derived macrophages resulted in increased HIV-1 production (Esser et al., 
1991, 1996, 1998). In contrast, ligation of TNF-ǂ to TNF-R2 resulted in inhibition of HIV-1 
replication (Herbein and Gordon, 1997).  
Interleukins 
IL-15 in acute HIV-infection 
The activation of DCs by HIV determines a progressive accumulation of various cytokines, 
including IL-15, which subsequently acts as potent inducer of NK cell activation and 
cytotoxicity. DC-NK cell cross-talk represents a key mode of the cellular network regulating 
the links between innate and the adaptive immune response (Moretta, 2002; Moretta et al., 
2006). IL-15 is produced during acute HIV-1 and SIV (simian immunodeficiency virus) 
infection and exerts an influence on viremia and viral set point. The viral set point was 
significantly increased during acute SIV-infection upon administration of IL-15. To identify 
cytokine biomarkers in plasma during acute HIV-1 infection that predict HIV disease 






months post infection. Only a small panel of plasma cytokines during acute HIV-1 infection 
was predictive of long-term HIV disease prognosis in this group, namely IL-12p40, IL-
12p70, IFN-, IL-7 and IL15. While IL-12p40, IL-12p70 and IFN- were significantly 
associated with lower viral load, IL-7 and IL-15 were associated with higher viral load 
(Roberts et al., 2010).  
IL-6 in acute HIV-infection 
IL-6 is a pro-inflammatory cytokine produced by macrophages, DCs, T and B cells in 
response to bacterial and viral infections. IL-6 mediates B cell stimulation, monocyte 
differentiation and induction of IL-4-producing cells (Rincon et al., 1997). It helps 
augmenting HIV-1 replication in macrophages and U1 cells (macrophage lineage) and 
enhances TNF-ǂ-induced up-regulation of HIV-1 production (Poli et al., 1990; Poli and 
Fauci, 1992). 
IL-10 in acute HIV-infection 
IL-10 is an anti-inflammatory cytokine produced by monocytes/macrophages, DCs and 
activated T and B cells. This cytokine blocks macrophage activation and inhibits secretion of 
the pro-inflammatory cytokines IL-1, IL-6, IL-8, IL-12 or TNF- (rev. in Moore et al, 2002). 
IL-10 was shown to interfere with HIV-infection at the early stages of HIV-1 infection 
although it does not alter CCR5 surface expression (Montaner et al., 1994; Wang et al., 1998). 
Pre-treatment of monocytes with IL-10 significantly decreased HIV-1 RNA expression and 
this inhibition of HIV replication was associated with down-modulation of IL-6- and TNF-a 
production by IL-10 (Weissman et al., 1994; Naif et al., 1994). 
2.3 Induction of -chemokines (MIP-1, MIP-1, RANTES) in acute HIV-infection 
MIP-1ǂ (CCL3) , MIP-1 (CCL4) and regulated upon activation normal T-cell expressed and 
secreted (RANTES, CCL5) were the first three factors of the -chemokine family identified 
as suppressors of HIV infection (Cocchi et al., 1995). These chemokines have been identified 
to bind the G-protein coupled receptors CCR5, which acts as co-factor for macrophage-(R5) 
and dual-(R5X4)-tropic HIV-1 strains. Similarly, the ligand of CXCR4, SDF-1 (CXCL12) was 
shown to suppress infection with T cell-(X4-)tropic HIV strains (Bleul et al., 1996; Oberlin et 
al., 1996). Polymorphisms in the CCR5 locus, in particular a 32 bp gene deletion (CCR532) 
results in a decreased susceptibility to infection with macrophage-(R5)-tropic HIV-1 strains 
(Kramer et al., 2005). CCR532- heterocygotic individuals can be infected with R5-tropic 
HIV, but exhibit a significantly slower disease progression, whereas CCR532-homocygotic 
individuals are susceptible to infection with X4-tropic HIV-1 strains.  
3. Interactions of HIV with cellular components of the innate immune system 
Very little is known respecting the earliest events after HIV transmission in the genital tract 
or the rectal mucosa and most findings about these early events were acquired from in vivo 
models of SIV-infected macaques (Haase, 2005). The in vivo SIV models and ex vivo analyses 
in the human system pursue to identify cells and soluble factors involved in HIV-
transmission (Haase, 2005; Hladik and McElrath, 2008). R5-tropic HIV-1 particles are 
selectively captured by epithelial cells and subsequently transfered to CCR5-expressing 
target cells underneath the epithelia. This could be responsible for the selective preferential 
transmission of R5-tropic HIV-1 strains (Meng et al., 2002). Langerhans cells (LCs) or other 
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dendritic cells are present at the port of the mucosal entry site (in the underlying tissues of 
the vagina and cervix) and trap pathogens with their processes that extend to the luminal 
surface. Thus, viruses cross the mucosal barrier by attachment or infection of DCs, by 
transcytosis (M cells) or by infection of intraepithelial lymphocytes and macrophages (Fig. 
3). Various cells of the innate immune system account for building the first line defense 
against HIV until the adaptive immune response is fully developed. Among those are LCs, 
myeloid DCs, pDCs, that recruite and activate NK cells (Fig. 3), macrophages, and NKT 
cells, which will be discussed in this part of the chapter. 
3.1 Dendritic cells in acute HIV infection 
Dendritic cells are the most potent antigen-presenting cells and can be divided into 
conventional myeloid DCs (LCs, dermal DCs, blood DCs) and plasmacytoid DCs (Table 1, 
adapted from Altfeld et al., 2011). They differ respecting their location, their C-type lectin and 
TLR expression, their role in HIV-infection, their cytokine production and their function 
(Table 1, Altfeld et al., 2011). As described very recently (Sabado et al., 2010), depletion of 
both, myeloid and plasmacytoid DCs from the circulation already occurs during the early 
 
 
Table 1. DC-subsets and functions during HIV-infection (adapted from Altfeld et al., 2011, 






phases of HIV infection. The depletion from the circulation is suggested to be due to 
preferential re-distribution of both DC types from blood to lymphoid organs. This re-
distribution is based on the ability of the DCs to up-regulate chemokine-receptor 7 (CCR7), 
that causes migration of DCs to the lymph nodes along a CCL19/CCL21 gradient. The 
reduction in circulating DC numbers was shown not to be transient, but also detectable in 
the chronic phase of infection and under highly-active antiretroviral therapy (Sabado et al., 
2010). Restoration of circulating DCs might represent a key factor in providing an improved 
immune response against the virus. 
3.1.1 Langerhans cells and HIV 
Langerhans cells (LCs) build the first line defense against mucosal infections because they 
are situated ideally in mucosal tissues to catch pathogens (Fig. 3). LCs survey the basal and 
suprabasal layers of the stratified squamous epithelium of the skin and oral and ano-genital 
mucosa for invading pathogens (Katz et al., 1979; Romani et al., 1985; rev. in DeJong and 
Geijtenbeek, 2010). Upon capture of Ags, LCs start to mature, which is represented by up-
regulation of CCR7, co-stimulatory molecules CD80/CD86/CD40, MHC class I and class II 
molecules and CD83 and by down-regulation of Langerin and E-cadherin (Merad et al., 
2008). These mature LCs migrate to the lymph node to present the captured Ag to T cells, 
thus inducing an efficient immune response (Merad et al., 2008). Despite their important 
function in initiating adaptive immune responses, LCs additionally exert innate immune 
functions as recently shown (De Witte et al., 2007). LCs characteristically express a specific 
set of TLRs (TLR2, 3, 5), high levels of CD1a, the C-type lectin Langerin and intracellular 
Birbeck granules that might be crucial to their innate function (Valladeau et al., 2000; Liu, 
2001; Flacher et al., 2006; Fahrbach et al., 2007, Romani et al., 2010). Langerin interacts with 
HIV-1 and other pathogens like fungi and bacteria. After heterosexual contact with an HIV-
infected individuum, the chance to acquire HIV-1 is very low (0.01-0.1%) (Wu and 
KewalRemani, 2006) and LCs are the first cells to encounter HIV due to their location in the 
mucosal stratified epithelium. Attachment of HIV-gp120 to Langerin leads to internalization 
of the viral particle and subsequent degradation in the Birbeck granules, that are 
characteristic for LCs (De Witte et al., 2007). Thus, LCs are protected from infection with 
incoming, non-opsonized HIV particles and HIV-1 is not disseminated through the host (De 
Witte et al., 2007). Although LCs express the primary receptor for HIV-1, CD4, and the 
chemokine co-receptor CCR5, they are not productively infected by the virus. This is 
probably due to efficient capture of the virus by Langerin and targeting of HIV-1 to Birbeck 
granules, where it is degraded (De Witte et al., 2007). The rapid internalization of HIV-1 into 
LCs prevents also transmission to the main target cells of the virus, CD4+ T cells. The 
degradation of HIV in Birbeck granules and the prevention of virus transfer to CD4+ T cells 
renders Langerin as a protective anti-HIV barrier. When, in addition, sexually transmitted 
infections (STIs) are present, the anti-HIV-1-barrier of LCs is abrogated and HIV-1 
transmission to CD4+ T cells by LCs is promoted (DeJong et al., 2008, 2010; Ogawa et al., 
2009). The by-passing of the anti-HIV-effect due to additional STIs results from direct 
interaction of the STIs with Langerin and therefore competition for HIV-1 binding, Langerin 
inhibition by high viral loads, lower Langerin surface expression by Poly(I:C) or HSV2 
(DeJong et al., 2010), up-regulation of HIV entry receptors and down-regulation of 
restriction factors (Ogawa et al., 2009), or inflammation-induced TNF- production by 
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Candida albicans or Neisseria gonorrhoea (DeJong et al., 2008). In summary, during acute co-
infection the anti-viral function of LCs is significantly reduced due to competition for 
Langerin. This facilitates HIV-1 infection of LCs and thereby promotes HIV-1 transfer to and 
infection of CD4+ T cells. 
3.1.2 Dermal dendritic cells and HIV 
In addition to LCs, interstitial dendritic cells are among the first cells to encounter HIV at 
mucosal surfaces (Fig. 3). They are underlying the epithelium and differ from LCs, since 
they do not contain Birbeck granules and express heterogenous amounts of CD1a (Bell et al., 
1999). Interstitial DCs are localized in the dermis and oral, vaginal and colonic lamina 
propria (Pavli et al., 1990, 1993; Lenz et al., 1993; Nestle et al., 1993; McLellan et al., 1998). 
They are characterized by the expression of CD11c, high concentrations of various C-type 
lectin receptors, TLRs 2, 3, 4 and 5 and secretion of IL-1, IL-6, IL-10, IL-12, IL-15, and IL-23 
upon pathogenic stimulation (Liu, 2001). Also dermal dendritic cells can be functionally 
divided in immature and mature DCs (iDCs, mDCs) based on their T cell stimulatory 
capacity (Banchereau and Steinman, 1998). Following antigen exposure, iDCs undergo 
major changes and mature (described under 3.1.1). Upon entry of HIV into the host, the 
virus has to be transported from mucosal surfaces to lymphatic tissues, where it is 
transmitted to its primary targets, CD4+ T lymphocytes. As mentioned above, this process is 
thought to be contrived by DCs. By clustering T cells, DCs may both activate antiviral 
immunity as well as facilitate spread of the virus. In vitro experiments showed that DCs 
efficiently capture and transfer HIV to T cells and initiated a vigorous infection (Pope et al., 
1995; McDonald et al., 2003; Pruenster/Wilflingseder et al, 2005; Wilflingseder et al, 2007). 
These experiments imply that in vivo HIV exploits DCs at mucosal sites as shuttles to CD4+ T 
cells in the lymph nodes. Preferential expression of CCR5 on immature LCs and DCs restricts 
the transmission of X4-tropic isolates at the site of infection. Additionally, ex vivo analyses 
revealed that X4-tropic HIV replicate worse in DCs and LCs compared to R5-tropic viruses 
(Granelli-Piperno et al, 1998; Kawamura et al, 2000; Ganesh et al, 2004). Productive infection of 
DCs and LCs with HIV is relatively inefficient compared to HIV-infection of CD4+ T cells and 
HIV- or SIV-infected DCs are rarely detected in vivo (rev. in Piguet and Steinman, 2007). Virus 
is very efficiently transmitted to T cells either via de novo (´cis´-transfer) or without (´trans´-) 
infection despite the low-level productive infection of DCs (Turville et al, 2004). Especially C-
type lectins such as Dendritic cell-specific ICAM-3-grabbing non-integrin (DC-SIGN) on 
dermal DCs was implicated in the transfer of HIV to T cells in the lymph nodes (Geijtenbeek et 
al., 2003; Turville et al., 2004). Similar to Langerin, DC-SIGN has high affinity for mannose and 
fucose structures. Dermal iDCs express the C-type lectin DC-SIGN and recently a second 
dermal DC subtype, expressing CD103 and Langerin, but no Birbeck granules, was described 
(Ginhoux et al., 2009). DC-SIGN captures low titres of HIV-1 through its interaction with the 
HIV-1 glycoprotein gp120 (Geijtenbeek et al., 2000) and this DC-SIGN/virus interaction 
protects HIV from degradation within the cells in contrast to the anti-viral action of Langerin 
on LCs (Geijtenbeek et al., 2000). DC-SIGN-complexed HIV-1 is stable and retains the 
infectivity for prolonged periods in contrast to DC-SIGN-bound antibody and probably other 
ligands that are internalized into lysosomal compartments for processing (Geijtenbeek et al., 
2000; Engering et al., 2002). These studies suggest that DC-SIGN-bound HIV-1 particles hide 
near the cell membrane in DCs and are not degraded. After ligating DC-SIGN, HIV is indeed 






to CD4+ T cells and also leads to enhancement of infection in these co-cultures and facilitates 
‘trans’-infection of the T cells (Geijtenbeek et al., 2000).  
Besides C-type lectins, other molecules, such as adhesion molecules e.g. ICAM-1 
(Pruenster/Wilflingseder et al, 2005) are described to further contribute to DC-HIV 
interaction. In all compartments tested so far (plasma, seminal fluid, lymphatic tissues), HIV 
is opsonized with C3 complement fragments and after seroconversion additionally with 
HIV-specific IgGs. Similar to the interaction of non opsonized HIV with C-type lectin 
receptors on DCs, receptors such as complement receptors (CRs) or Fc receptors (FcR) 
contribute to the attachment of the complement- or IgG-coated virus. If the virus is 
opsonized, the DC-SIGN- or ICAM-dependent interactions play a minor role for the 
attachment of HIV to DCs as well as the DC-mediated cis and trans HIV-infection 
(Pruenster/Wilflingseder et al, 2005). Complement-opsonization of HIV significantly 
enhanced the productive infection of DCs compared to non-opsonized HIV and also acted 
as an endogenous adjuvant for the DC-mediated induction of virus-specific CTLs 
(Wilflingseder et al., 2007; Banki/Posch et al., 2010). These results emphasize a role of DCs 
in combination with complement-coating of the virus in priming adaptive T cell responses. 
Vigorous trans-infection of CD4+ T cells by DCs was shown to be promoted by infectious 
synapse formation independent on the attachment mechanism (C-type lectin receptors, 
adhesion molecules, CRs [own unpublished observations]) (rev. by Piguet and Sattentau, 
2004). The receptors involved in the HIV attachment have to be re-arranged and are 
recruited to the DC-T cell junctions (McDonald et al., 2003). Microscopic analyses of DC-
CD4+ T cells revealed re-arrangement and recruitment of CD4 and chemokine-co-receptor to 
the infectious synapse on the T cell site and of HIV on the DC site (McDonald et al., 2003). 
Thereby, dermal DCs contribute not only to shuttle HIV from the mucosal site to the 
lymphatic tissue but also to efficiently transmit of HIV to its main targets, CD4+ T cells. 
Beside the support of DCs in HIV dissemination, DCs produce high amounts of cytokines, 
such as IL-12 or interferons, which belong to the first line of the host defense against invading 
organisms. They are also able to activate NK cells via secretion of pro-inflammatory cytokines 
(IL-12, IL-15, IL-18) and other factors, thus enhancing their cytotoxicity to virally infected cells 
(Chehimi et al., 1989; Mellman and Steinman, 2001, Yu et al., 2001).  
In terms of modulation of DC function by HIV infection in vivo, it is not clear if DC defects 
are resulting from the direct exposure to HIV or if they are due to production of host cell 
factors during infection. Circulating lipopolysaccharide (LPS) or other pathogen-derived 
factors were also implicated in chronic immune activation, which is monitored during HIV 
infection (Brenchley et al., 2006). Bacterial stimuli like LPS could result in maturation of 
iDCs thus rendering these cells tolerant to subsequent stimuli. Ex vivo tests of DCs from 
chronically infected individuals demonstrated that they were less potent in responding to 
other TLR stimuli as well as in stimulating T cell responses compared to DCs from non-
infected individuals (Donaghy et al., 2003; Martinson et al., 2007). 
DCs are furthermore involved in the generation of regulatory T cells and thus induce both, 
immunity and tolerance. DCs shown to induce tolerance are plasmacytoid DCs (pDCs). 
(Steinman, 2000).  
3.1.3 pDCs and HIV 
Plasmacytoid DCs or type 1 IFN-producing cells, are innate immune cells specialized in 
releasing massive amounts of IFN and IFN upon viral challenge, including HIV (Fig. 3) 
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(Siegal et al., 1999). This blood DC population expresses high levels of HLA-DR and the 
characteristic markers BDCA-2 and CD123 (Table 1), but not CD11c, a marker of myeloid 
DCs (Table 1) (O´Doherty et al., 1994; Dzionek et al., 2001). pDCs are key initiators of the 
innate immune response in vivo and they can prime adaptive immunity due to the afore 
mentioned production of high type I interferon levels, especially upon exposure to viral 
products (Cella et al., 1999; Siegal et al, 1999). pDCs recognize pathogenic single-stranded 
RNA or unmethylated DNA mainly by TLR7 and TLR9. Due to the intracellular localization 
of these TLRs, the viruses have to be ingested by the cells and endosomal maturation must 
occur to activate NFkB- and MAPK-signals through MyD88. Once activated, pDCs mature 
and produce large amounts of pro-inflammatory and antiviral cytokines (Kadowaki et al., 
2000; Ito et al., 2002; Colonna et al., 2004). pDCs do not only act as pro-inflammatory cells, 
but also provide negative regulatory signals and thereby induce tolerance (Ochando et al., 
2006). pDCs express indoleamine 2,3-dioxygenase (IDO) and programmed death ligand 1 
(PDL-1) that are associated with the negative modulation of T cell responses and regulatory 
T cell induction (Boasso et al., 2007, 2008; Chen et al., 2008). As shown, constant exposure of 
pDCs to HIV results in their chronic hyperactivation coming along with production of type I 
interferon and IDO, which exerts cytotoxic as well as suppressive effects on T cells 
(Herbeuval and Shearer, 2007). In acute HIV-infection pDCs recruit and activate NK cells to 
the sites of infection as well as to the lymph nodes (Gerosa et al., 2002; Megjugorac et al., 2004). 
The activation is due to IFN released from pDCs, which was demonstrated to induce 
increased perforin expression in NK and CD8+ T cells. The pDC-NK cell activation is bi-
directional, since activated NK cells deplete immature pDCs to possibly select the more 
immunogenic mature pDCs at the sites on infection (Pertales et al., 2003a, 2003b; Ferlazzo and 
Munz, 2004). This process is called ‘DC-editing’ (Ferlazzo et al., 2002). Beside NK cell 
recruitment and activation, pDC-produced IFN promotes maturation and migration of DCs. 
pDCs are not as efficient in antigen-presentation as myeloid DCs and they are not located in 
high amounts at the site of pathogen entry. Due to their spontaneous antiviral and NK 
priming activity they are supposed to control the virus in the acute phase of infection and it 
is unlikely that they are involved in HIV capture, transport and transmission. 
Deficiencies in pDC function were among the earliest observations of immune dysfunction 
in HIV-1 infection. Loss of pDCs in blood of chronically infected individuals has been 
ascribed to cell death and/or to a failure of bone marrow progenitors to differentiate into 
pDCs. Additionally, a low productive virus replication of IFN-producing pDCs has been 
shown in vivo and in vitro by R5- and X4-tropic HIV variants (Donaghy et al., 2003; Schmidt 
et al, 2004). It is not known so far, if infection of pDCs plays a role for IFNǂ-secretion. 
3.2 NK and NK T cells in acute HIV infection 
Natural killer (NK) cells are lymphocytes deriving from bone marrow precursors. They 
circulate as mature populations in blood and spleen and are activated by type I interferons 
(Fig. 3). Classical NK cells do not express T cell antigen receptors (TCR) and are CD3-
negative. They produce high levels of certain cyto- and chemokines, such as MIP-1ǂ, MIP-
1, RANTES, TNFǂ, GM-CSF or IFN-and mediate significant levels of cytotoxic activity by 
exocytosis of granules containing perforin and granzymes. NK cells thus efficiently 
contribute to innate immune responses due to their spontaneous cytotoxic action against 






balance of activating and inhibitory NK cell receptors (Moretta et al, 2001; Moretta, 2002; 
Lanier, 2005) and they are able to kill HIV-infected target cells by direct lysis or by antibody-
dependent cell-mediated cytotoxicity (ADCC) (Tasca et al, 2003; Bonaparte and Barker, 
2004). ADCC is mediated in classical NK cells through their cell surface receptors for 
immunoglobulins (FcR). Additionally, NK cells initiate priming of the adaptive immunity 
due to their cross-talk with DCs. As mentioned above, NK cells activate DCs by cell-cell 
contact or secretion of cytokines and vice versa, DC-derived cytokines and membrane-
bound molecules play a key role in NK cell activation (Zitvogel, 2002; Andrews et al, 2003; 
Ferlazzo et al, 2004; Cooper et al., 2004; Moretta et al, 2006; Newman et al, 2006). Their killer 
inhibitory receptors (KIRs), which transmit an inhibitory signal, if they encounter MHC 
class I molecules on a cell surface, are crucial in killing virus-infected cells. Two subsets of 
classical NK cells can be distinguished by their expression of CD16 and CD56. >95% of the 
NK cells belong to the CD16highCD56low subset, which is responsible for the direct lysis of 
cells and the ADCC (Nagler et al, 1989; Caligiuri et al, 1990). The remaining 5% CD16low/-
CD56high subset produces high concentrations of IFN- and TNF-ǂ, but this sub-population 
exerts a very low cytotoxic potential (Ahmad and Menezes, 1996). In HIV-infected 
individuals NK cell responses were shown to be impaired and the defects comprised 
cytotoxic activity of NK cells as well as secretion of CCR5-ligands MIP1ǂ, MIP1 and 
RANTES (Scott-Algara et al, 1992; Mavilio et al, 2003; Kottilil, 2003). The HIV-mediated 
impairment of NK cells becomes manifest early after infection and continues during HIV 
progression and can be attributed to several factors:  
HIV-infected individuals might have a down-regulation in intracellular perforin and 
granzyme A stores, which would account for the decreased cytotoxic capacity of NK cells in 
HIV-infection (Portales et al., 2003). 
Another explanation might be the change in the expression patterns of various activating 
and inhibitory NK cell receptors during HIV-infection (DeMaria et al., 2003). 
Chronic viral stimulation may also lead to inappropriate activation of peripheral NK cells, 
thus resulting in NK cell exhaustion or anergy (Alter et al., 2005; Mavilio et al., 2005).  
Finally, CD4+ NK cells may be a reservoir for HIV-1 in vivo and further investigation is 
necessary to explore this possibility. 
A population of T cells sharing characteristics with classical NK cells has been identified 
based on expression of NK cell markers, and this population was named NK T cells 
(McDonald, 1995). NK T cells, a rare population of T lymphocytes, comprise only 0.01 ~ 1% 
of human peripheral blood mononuclear cells and play an important role in the innate 
immune defense (Motsinger et al, 2002). NK T cells are important immunoregulatory cells, 
producing both, high amounts of IFN- ( double-negative NK T cells), a major TH1 
cytokine, and IL-4 and IL-13 ( CD4+ NK T cells), the major TH2 type cytokines (Gumperz et 
al, 2002; Lee et al, 2002). Thus NK T cells may provide quicker help for a cell- (IFN-) or 
antibody-mediated (IL-4) response than conventional T cells through recruiting and 
stimulating other effector cells, such as NK cells, macrophages, DCs and conventional T 
cells. NK T cells can in addition act directly cytolytic through involving the 
perforin/granzymes and the Fas/FasL pathway (Metelitsa et al., 2001).  
A semi-invariant TCR (NK T TCR) is expressed on NK T cells consisting of an invariant -
chain, and a restricted TCR--chain repertoire (rev. in Godfrey and Kronenberg, 2004). NK T 
cells recognize self or foreign glycolipids presented by the non-polymorphic MHC class I-
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like molecule CD1d (Bendelac et al, 1997; Joyce, 2001). NK T cells are stimulated by type I 
interferons or pro-inflammatory cytokines (IL-15, IL-12, IL-18). Therefore, also NK T cells 
need a cross-talk with DCs to be fully activated (pDCs  type I IFNs, DCs  IL-12).  
Upon HIV-1 infection NK T cells are rapidly and selectively depleted from the circulation. 
The NK T cell numbers are dramatically reduced in HIV-infected individuals compared to 
healthy donors (Motsinger et al., 2002; Van der Vliet et al, 2004). In vivo studies showed that 
the decrease in NK T cell numbers significantly correlated with higher viral loads in infected 
individuals (Motsinger et al., 2002) and that these HIV-susceptible cells were rapidly 
destroyed in vitro by R5-tropic HIV-strains (Motsinger et al., 2002). The mature NK T 
phenotype is induced by persistent stimulation of the cells with unidentified self-Ags or Ag-
independent mechanisms and the high expression of CCR5 on the surface renders NK T 
cells permissive for HIV. They are not only efficiently infected by HIV but also contribute to 
the viral spread due to activating resting by-stander CD4+ T cells (Unutmaz et al., 1999).  
The rapid loss of NK T cells during early HIV-infection causes subsequent depletion of 
important immunoregulatory functions, which are involved in tumor immunity, defense 
against other invading pathogens and autoimmune diseases. This might facilitate 
establishment of other opportunistic infections or tumor development frequently detected at 
later stages of the disease. NKT cells are important cells of the innate immune system, which 
are selectively and rapidly depleted by HIV-1 infection. Stimulation of the surviving NK T 
cells is additionally impeded due to down-regulation of CD1d on antigen-presenting cells.  
 
 






3.3 Macrophages in acute HIV infection 
Macrophages resident at mucosal sites are proposed to play an important role during 
HIV-1 pathogenesis. Macrophages bridge innate and adaptive immunity similar to DCs, 
NK and NK T cells. They are recognizing, internalizing and degrading microorganisms 
and clear cell debris via TLRs, C-type lectins (Dectin-1), Fc receptors and complement 
receptor 3. Furthermore, macrophages present pathogen-derived peptides via MHC class 
II, thus initiating adaptive immune responses, and secret pro-inflammatory cytokines. 
Upon HIV-infection they are among the first cells encountered by the virus, but they are 
able to resist to HIV-mediated cytopathic effects. Therefore, macrophages are thought to 
serve as major cellular HIV reservoir together with latently infected resting CD4+ T cells 
for long-term infection. Productively infected macrophages were detected in both 
untreated patients and those receiving antiretroviral therapy (ART), but the HIV infection 
within macrophages was not associated with virus-induced cytopathic effects (Koenig et 
al, 1986; Sharkey et al, 2000). The infectious virus is retained in macrophages for a 
prolonged period of time and the virus may be released from macrophages delayed and 
in a different compartment – thus macrophages contribute to persistence and spread of 
the virus (Crowe et al., 2003; Montaner et al., 2006; Carter and Ehrlich, 2008). As detected 
in NK or NK T cells, the functions of macrophages were found to be impaired by HIV-1 
infection in vitro and in vivo. In vivo macrophages from HIV-infected individuals were 
found to be defective for phagocytosis of apopotic cells (Torre et al., 2002). In vitro HIV-1 
impeded with phagocytosis via CR3 or FcR and also impaired internalization of Candida 
albicans and Toxoplasma gondii (Crowe et al., 1994; Kedzierska et al., 2002; Azzam et al., 
2006; Leeansyah et al., 2007). As recently shown, Nef was a crucial factor in disrupting 
phagocytosis in HIV-1–infected cells (Mazzolini et al., 2010). 
HIV and its accessory genes alter macrophage immune responses, macrophage cell cycle 
and enhance their own viral replication in macrophages (Margottin et al, 1998; Hassaïne et 
al, 2001; Federico et al, 2001; Coberley et al, 2004; Olivetta et al, 2005). HIV mediated a pro-
inflammatory gene expression pattern in macrophages as demonstrated by microarray 
analyses, and this pro-inflammatory cytokine profile is suggested to enhance virus 
replication and persistence of chronically activated macrophages in vivo. In addition to up-
regulation of pro-inflammatory cytokines, IFN- and NFB-responsive cyto- and chemokines 
were increased upon HIV-1 infection. Up-regulation of these IFN- and NFB-responsive 
cyto- and chemokines may promote recruitment of CD4+ T cells and macrophages to sites of 
infection, which would promote the viral spread (Cicala et al, 2002; Izmailova et al, 2003; 
Woelk et al, 2004). Only low expression levels of CD4 are detected on the surface of 
macrophages; in contrast high levels of heparan sulfate proteoglycans (such as syndecan), 
macrophage mannose receptor (MR), and elastase are expressed (Nguyen and Hildreth, 
2003; Bristow et al, 2003; De Parseval et al, 2005). HIV can attach and internalize into 
macrophages via these receptors. Expression of both chemokine co-receptors, CCR5 and 
CXCR4, was verified on primary human macrophages, and they can be infected with R5-, 
dual- and X4-tropic virus isolates in vitro and in vivo (Verani et al, 1998; Liu et al, 1996; 
Samson et al, 1998; Clapham and McKnight, 2002). Once ingested by macrophages, HIV 
accumulates in endocytic compartments similar to multivesicular bodies, which facilitate 
HIV assembly and escape immune surveillance (Kramer et al, 2005). This accumulation of 
HIV in the cytoplasmic vesicles of macrophages results in persistent storage of infectious 
virions and a delayed rapid infection of CD4+ T cells (Sharova et al, 2005). When a 
virological synapse is formed between a macrophage and a T cell, the virus is efficiently 
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transmitted. Therefore tissue macrophages were claimed to act as ´Trojan horse´, that hide 
the virus from the immune system and disseminate the virus even after months.  
3.4 Monocytes in acute HIV infection 
Similar to DCs, LCs and macrophages, monocytes provide a first line of defense against 
invading pathogens and act as key mediators of innate immune mechanisms. On the other 
hand, they are also targets for monocyte-tropic pathogens, such as Listeria, cytomegalovirus 
and HIV (Drevets and Leenen, 2000). Monocytes express CD4, CCR5 and CXCR4 and are in 
particular susceptible to macrophage-tropic HIV strains. Similar to macrophages, monocytes 
are resistant to the cytopathic effects of HIV, they represent a key virus reservoir and may 
also disseminate HIV in different locations such as the brain (Kedzierska and Crowe, 2002; 
Crow et al., 2003). Early in acute infection, HIV and SIV enter the central nervous system 
(CNS) and macrophages and monocytes seem to play a crucial role in the 
neuropathogenesis of HIV-infection and to contribute to HIV-mediated dementia due to 
production of pro-inflammatory cytokines and neurotoxins (Chakrabarti et al., 1991; 
Kedzierska and Crowe, 2002). The induction of pro-inflammatory cytokines is thought to 
facilitate the entry of monocytes into the brain by disrupting the blood-brain and blood-
cerebrospinal fluid barrier (Persidsky et al., 2000; Eugenin and Berman, 2003). In particular, 
CCL2 was associated with inflammation of the CNS (Mahad and Ransohoff, 2003). This 
cytokine is mainly secreted by monocytes and macrophages and initiates migration of T 
cells and other monocytes into the CNS and promotion of neuronal cell-death during HIV 
and SIV infection (Gartner and Liu, 2002; Fantuzzi et al., 2003). HIV-1 Tat activates microglial 
and perivascular cells to produce pro-inflammatory proteins, thereby leading to monocyte 
infiltration into the brain (Pu et al, 2003). Other features promoted by Tat following infection 
with HIV were chemotaxis of monocytes, their adhesion to the endothelium, and their 
recruitment into extra-vascular tissues. This modulation of the chemotactic activity seems to be 
mediated by the Tat cysteine-rich domain (Albini et al, 1998). 
Thus, monocytes represent a prinicpal reservoir for HIV persistence due to the long storage 
period of infectious viral particles and infectious HIV was shown to be recovered from 
patients obtaining ART. HIV thus affects multiple immune functions of 
monocytes/macrophages (chemotaxis, phagocytosis, intracellular killing, APC function, 
cytokine production) and thereof allows establishment as well as re-activation of other 
opportunistic infections (Kedzierska and Crowe, 2002).  
3.5 T cells in acute HIV infection 
T cells are primarily situated in the gastrointestinal mucosa and play an important role in 
the first line of defense against viral, bacterial, and fungal pathogens. T cells make up 50% 
of all lymphocytes in the intraepithelial compartment and about 10% of lymphocytes in the 
lamina propria (James et al., 1986; Targan et al., 1995). T cells recognize soluble protein 
and non-protein Ags, but the mechanism of recognition remains elusive. T cells 
participate in the immune response to various viruses, including herpes simplex virus, 
Epstein-Barr virus, and HIV-1 (Maccario et al., 1995). Co-culture of T cells with HIV-1 
infected lymphocytes resulted in increased cytotoxicity and production of HIV-1-suppresive 
mediators against the infected cells (Wallace et al., 1996; Poccia et al., 1999; Cipriani et al., 






cells during acute infection and, despite HAART, persist into the chronic phase, but the 
factors involved in these changes remain to be investigated. 
4. Conclusions 
In summary, innate immune responses contribute significantly to the first line of defense 
against invading HIV-1 particles on the one hand, but the virus has evolved different 
strategies to escape from the innate immune system on the other hand. While Langerhans 
Cells and plasmacytoid dendritic cells exert efficient antiviral actions by degrading the virus 
via Birbeck granules (LCs) or secreting high amounts of type I interferons (especially IFNǂ), 
interstitial dermal dendritic cells are suggested to contribute in viral transport and 
dissemination. The antiviral functions of LCs are also reversed upon co-infection with other 
STIs or microbes due to the competition of the pathogens for Langerin. The competition for 
Langerin allows attachment of HIV-1 to its main receptors, CD4 and the chemokine-co-
receptor CCR5, on LCs and thus facilitates infection of LCs and subsequent transfer to CD4+ 
T cells in the lymph nodes. This process of ‘cis’-infection of DCs, migration to the lymphatic 
tissues and transmission to CD4+ T cells is also thought to be contrived by dermal DCs. The 
virus is furthermore efficiently protected against complement-mediated lysis due to 
acquisition of regulators of complement activation during the budding process from the 
host cell (CD55, CD59) and additionally in fluid-phase (fH). Thus, most of the virus is 
opsonized with C3-fragments in vivo, which allows interaction with complement-receptor 
expressing cells at mucosal surfaces. Therefore the host immune system itself has to reverse 
the protection of the virus against complement-mediated lysis. As recently demonstrated 
(Banki/Posch et al., 2010), complement-opsonization acts as endogenous adjuvant for the 
dendritic cell-mediated induction of retrovirus-specific CTLs in vitro and in vivo, which was 
the first evidence that specific CTLs are efficiently stimulated in a complement- and DC-
dependent manner. This enhanced and efficient CTL-stimulatory capacity of DCs upon 
complement-opsonization of HIV may provide a host-cell protecting mechanism at the 
beginning of infection and understanding the exact interplay between differentially 
opsonized retroviral particles and APCs is of prime importance for DC-based vaccination 
strategies against retroviral infections. Not only benefits result from the complement 
opsonization of HIV- such complement-opsonized particles can also be ingested by CR3-
expressing macrophages and monocytes, the major reservoirs of long-term HIV-persistence 
beside latently infected CD4+ T cells. These cells facilitate HIV assembly and escape immune 
surveillance by hiding the particles from the immune system and by allowing efficient 
transfer of the particles to target cells in a delayed manner and another compartment. 
Instead of destroying the virus at the initial phases of infection, macrophages and 
monocytes seem to act as ´Trojan horse´ by actively contributing to the spread of HIV over 
long time periods. Beside LCs and pDCs, T cells, primarily located in the gastrointestinal 
mucosa, NK and NK T cells, that are activated by IFN-secreted pDCs, build an important 
first line of defense against viral, bacterial, and fungal pathogens. HIV-1 counteracts this 
innate immune barrier by changing their functions and decreasing their numbers by yet 
mainly undefined mechanisms. The HIV-mediated loss in numbers of important innate 
immune cells, such as pDCs, NK and NK T cells or T cells, is associated with a modified 
cytokine microenvironment, which may additionally account for the chronic establishment 
of HIV-infection in the host. Because it is difficult identifying infected individuals very soon 
after exposure, little is known respecting the earliest events of HIV transmission in the 
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genital tract or rectal mucosa. Most of the findings are deriving from in vivo models of SIV 
infection (rev. in Haase, 2005) and from ex vivo models aimed to identify cells and factors 
affecting the transmission of HIV (rev. in Hladik and McElrath, 2008). Even when using 
animal models the exact process how the virus infiltrates mucosal barriers to establish a 
productive infection in the host is extremely complex to evaluate. There are multiple innate 
soluble and cellular factors acting together upon entry of HIV into the host – yet, the innate 
mechanisms and even the specific adaptive immune responses fail to restrict the replication 
of HIV in most infected individuals indicating the selection of viral mutants that are able to 
efficiently escape these early and late cellular and humoral immune responses. In the last 
years, increasing evidence suggests that especially immunologic and virologic events 
occuring during primary infection irreversibly weaken the immune system, which is not 
able to restore and gradually fails to resist viral and opportunistic infections. 
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